Postdoc in lipidomics at the Department of Drug Design and Pharmacology

We are looking for a highly motivated and dynamic postdoc for a 3 year position starting on February 1st 2027, or as soon as possible hereafter.

This post-doc project aims at developing analytical methods to identify and quantify gangliosides and glucosylsphingosine and to combine them with existing methods available at the Lipidomics Core Facility at the Danish Cancer Institute (DCI) to analyse post-mortem brain samples and stem cell derived brain cells from patients with Parkinson’s Disease in order to identify lipid changes associated with the disease pathology.

Information on the department can be found at: https://drug.ku.dk Our research The project will be anchored at the Galvagnion group and be in collaboration with Dr Mesut Bilgin and Dr Kenji Maeda at the Lipidomics Core Facility at the DCI.

The Galvagnion group research aims at understanding the role of dysfunctions in lipid homeostasis in the emergence of neurodegenerative diseases including Alzheimer’s and Parkinson’s Diseases. Our approach consists in identifying, using biological models, lipid changes associated with these dise1 …